Recall of Promacta (eltrombopag) 12.5 oral suspension by Novartis due to potential peanut contamination.
More on the FDA website:
www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/novartis-issues-voluntary-nationwide-recall-promactar-125-mg-oral-suspension-due-potential-peanut